Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Neoplasms of the CNS

  Free Subscription


Articles published in BMC Cancer

Retrieve available abstracts of 71 articles:
HTML format
Text format



Single Articles


    August 2017
  1. NOH MG, Oh SJ, Ahn EJ, Kim YJ, et al
    Prognostic significance of E-cadherin and N-cadherin expression in Gliomas.
    BMC Cancer. 2017;17:583.
    PubMed     Text format     Abstract available


    July 2017
  2. ZINDLER JD, Bruynzeel AME, Eekers DBP, Hurkmans CW, et al
    Whole brain radiotherapy versus stereotactic radiosurgery for 4-10 brain metastases: a phase III randomised multicentre trial.
    BMC Cancer. 2017;17:500.
    PubMed     Text format     Abstract available


  3. MIELE E, Po A, Begalli F, Antonucci L, et al
    beta-arrestin1-mediated acetylation of Gli1 regulates Hedgehog/Gli signaling and modulates self-renewal of SHH medulloblastoma cancer stem cells.
    BMC Cancer. 2017;17:488.
    PubMed     Text format     Abstract available


    June 2017
  4. WIBROE M, Cappelen J, Castor C, Clausen N, et al
    Cerebellar mutism syndrome in children with brain tumours of the posterior fossa.
    BMC Cancer. 2017;17:439.
    PubMed     Text format     Abstract available


  5. HAYASHI N, Takahashi H, Hasegawa Y, Higuchi F, et al
    A nationwide multi-institutional retrospective study to identify prognostic factors and develop a graded prognostic assessment system for patients with brain metastases from uterine corpus and cervical cancer.
    BMC Cancer. 2017;17:397.
    PubMed     Text format     Abstract available


    April 2017
  6. URUP T, Staunstrup LM, Michaelsen SR, Vitting-Seerup K, et al
    Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients.
    BMC Cancer. 2017;17:278.
    PubMed     Text format     Abstract available


  7. TRUBICKA J, Zemojtel T, Hecht J, Falana K, et al
    The germline variants in DNA repair genes in pediatric medulloblastoma: a challenge for current therapeutic strategies.
    BMC Cancer. 2017;17:239.
    PubMed     Text format     Abstract available


    March 2017
  8. DALAN AB, Gulluoglu S, Tuysuz EC, Kuskucu A, et al
    Simultaneous analysis of miRNA-mRNA in human meningiomas by integrating transcriptome: A relationship between PTX3 and miR-29c.
    BMC Cancer. 2017;17:207.
    PubMed     Text format     Abstract available


  9. NARAYAN RS, Fedrigo CA, Brands E, Dik R, et al
    The allosteric AKT inhibitor MK2206 shows a synergistic interaction with chemotherapy and radiotherapy in glioblastoma spheroid cultures.
    BMC Cancer. 2017;17:204.
    PubMed     Text format     Abstract available


  10. JENSEN SS, Petterson SA, Halle B, Aaberg-Jessen C, et al
    Effects of the lysosomal destabilizing drug siramesine on glioblastoma in vitro and in vivo.
    BMC Cancer. 2017;17:178.
    PubMed     Text format     Abstract available


    February 2017
  11. DEWAN R, Pemov A, Dutra AS, Pak ED, et al
    First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.
    BMC Cancer. 2017;17:127.
    PubMed     Text format     Abstract available


  12. LI Y, Li J, Woo YM, Shen Z, et al
    Enhanced expression of Vastatin inhibits angiogenesis and prolongs survival in murine orthotopic glioblastoma model.
    BMC Cancer. 2017;17:126.
    PubMed     Text format     Abstract available


  13. SHANNON S, Jia D, Entersz I, Beelen P, et al
    Inhibition of glioblastoma dispersal by the MEK inhibitor PD0325901.
    BMC Cancer. 2017;17:121.
    PubMed     Text format     Abstract available


  14. GERSEY ZC, Rodriguez GA, Barbarite E, Sanchez A, et al
    Curcumin decreases malignant characteristics of glioblastoma stem cells via induction of reactive oxygen species.
    BMC Cancer. 2017;17:99.
    PubMed     Text format     Abstract available


    January 2017
  15. DENG X, Zheng Z, Lin B, Su H, et al
    The efficacy and roles of combining temozolomide with whole brain radiotherapy in protection neurocognitive function and improvement quality of life of non-small-cell lung cancer patients with brain metastases.
    BMC Cancer. 2017;17:42.
    PubMed     Text format     Abstract available


  16. RADES D, Janssen S, Dziggel L, Blanck O, et al
    A matched-pair study comparing whole-brain irradiation alone to radiosurgery or fractionated stereotactic radiotherapy alone in patients irradiated for up to three brain metastases.
    BMC Cancer. 2017;17:30.
    PubMed     Text format     Abstract available


  17. FROMBERG A, Rabe M, Oppermann H, Gaunitz F, et al
    Analysis of cellular and molecular antitumor effects upon inhibition of SATB1 in glioblastoma cells.
    BMC Cancer. 2017;17:3.
    PubMed     Text format     Abstract available


    December 2016
  18. YOMO S, Hayashi M
    Is upfront stereotactic radiosurgery a rational treatment option for very elderly patients with brain metastases? A retrospective analysis of 106 consecutive patients age 80 years and older.
    BMC Cancer. 2016;16:948.
    PubMed     Text format     Abstract available


    November 2016
  19. WONG ET, Timmons J, Callahan A, O'Loughlin L, et al
    Phase I study of low-dose metronomic temozolomide for recurrent malignant gliomas.
    BMC Cancer. 2016;16:914.
    PubMed     Text format     Abstract available


  20. MUROTA Y, Tabu K, Taga T
    Requirement of ABC transporter inhibition and Hoechst 33342 dye deprivation for the assessment of side population-defined C6 glioma stem cell metabolism using fluorescent probes.
    BMC Cancer. 2016;16:847.
    PubMed     Text format     Abstract available


    October 2016
  21. OEHLKE O, Mix M, Graf E, Schimek-Jasch T, et al
    Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) - protocol of a randomized phase II trial (NOA 10/ARO 2013-1).
    BMC Cancer. 2016;16:769.
    PubMed     Text format     Abstract available


    April 2016
  22. GRAMATZKI D, Roth P, Felsberg J, Hofer S, et al
    Chemotherapy for intracranial ependymoma in adults.
    BMC Cancer. 2016;16:287.
    PubMed     Text format     Abstract available


    January 2016
  23. AKIMOTO J, Fukuhara H, Suda T, Nagai K, et al
    Clinicopathological analysis in patients with neuroendocrine tumors that metastasized to the brain.
    BMC Cancer. 2016;16:36.
    PubMed     Text format     Abstract available


  24. ZHANG C, Zhu Q, He H, Jiang L, et al
    Erratum to: RIZ1: a potential tumor suppressor in glioma.
    BMC Cancer. 2016;16:26.
    PubMed     Text format    


  25. LEGENDRE C, Avril S, Guillet C, Garcion E, et al
    Low oxygen tension reverses antineoplastic effect of iron chelator deferasirox in human glioblastoma cells.
    BMC Cancer. 2016;16:51.
    PubMed     Text format     Abstract available


  26. DIETL S, Schwinn S, Dietl S, Riedel S, et al
    MB3W1 is an orthotopic xenograft model for anaplastic medulloblastoma displaying cancer stem cell- and Group 3-properties.
    BMC Cancer. 2016;16:115.
    PubMed     Text format     Abstract available


  27. SIVAK S, Kantorova E, Kurca E, Marcinek J, et al
    Primary diffuse leptomeningeal gliomatosis as a rare cause of pain in cervical spine.
    BMC Cancer. 2016;16:182.
    PubMed     Text format     Abstract available


  28. AYALA-ORTEGA E, Arzate-Mejia R, Perez-Molina R, Gonzalez-Buendia E, et al
    Epigenetic silencing of miR-181c by DNA methylation in glioblastoma cell lines.
    BMC Cancer. 2016;16:226.
    PubMed     Text format     Abstract available


  29. CHRISTENSEN TD, Spindler KL, Palshof JA, Nielsen DL, et al
    Systematic review: brain metastases from colorectal cancer-Incidence and patient characteristics.
    BMC Cancer. 2016;16:260.
    PubMed     Text format     Abstract available


  30. LUSSIER DM, Woolf EC, Johnson JL, Brooks KS, et al
    Enhanced immunity in a mouse model of malignant glioma is mediated by a therapeutic ketogenic diet.
    BMC Cancer. 2016;16:310.
    PubMed     Text format     Abstract available


  31. NAVARRIA P, Pessina F, Cozzi L, Ascolese AM, et al
    Can advanced new radiation therapy technologies improve outcome of high grade glioma (HGG) patients? analysis of 3D-conformal radiotherapy (3DCRT) versus volumetric-modulated arc therapy (VMAT) in patients treated with surgery, concomitant and adjuvan
    BMC Cancer. 2016;16:362.
    PubMed     Text format     Abstract available


  32. CHEN BB, Lu YS, Lin CH, Chen WW, et al
    A pilot study to determine the timing and effect of bevacizumab on vascular normalization of metastatic brain tumors in breast cancer.
    BMC Cancer. 2016;16:466.
    PubMed     Text format     Abstract available


  33. GROSSMANN P, Gutman DA, Dunn WD Jr, Holder CA, et al
    Imaging-genomics reveals driving pathways of MRI derived volumetric tumor phenotype features in Glioblastoma.
    BMC Cancer. 2016;16:611.
    PubMed     Text format     Abstract available


  34. BALBOUS A, Cortes U, Guilloteau K, Rivet P, et al
    A radiosensitizing effect of RAD51 inhibition in glioblastoma stem-like cells.
    BMC Cancer. 2016;16:604.
    PubMed     Text format     Abstract available


  35. NETLAND IA, Forde HE, Sleire L, Leiss L, et al
    Dactolisib (NVP-BEZ235) toxicity in murine brain tumour models.
    BMC Cancer. 2016;16:657.
    PubMed     Text format     Abstract available


  36. AMANI V, Prince EW, Alimova I, Balakrishnan I, et al
    Polo-like Kinase 1 as a potential therapeutic target in Diffuse Intrinsic Pontine Glioma.
    BMC Cancer. 2016;16:647.
    PubMed     Text format     Abstract available


  37. CHOI SA, Kwak PA, Kim SK, Park SH, et al
    In vivo bioluminescence imaging for leptomeningeal dissemination of medulloblastoma in mouse models.
    BMC Cancer. 2016;16:723.
    PubMed     Text format     Abstract available


  38. SCHORB E, Finke J, Ferreri AJ, Ihorst G, et al
    High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma-a randomized phase III trial (MATRix).
    BMC Cancer. 2016;16:282.
    PubMed     Text format     Abstract available


  39. NIIBE Y, Nishimura T, Inoue T, Karasawa K, et al
    Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects.
    BMC Cancer. 2016;16:659.
    PubMed     Text format     Abstract available


    May 2015
  40. KIM DW, Barcena E, Mehta UN, Rohlfs ML, et al
    Prolonged survival of a patient with metastatic leptomeningeal melanoma treated with BRAF inhibition-based therapy: a case report.
    BMC Cancer. 2015;15:400.
    PubMed     Text format     Abstract available


    April 2015
  41. GAO Y, Li G, Sun L, He Y, et al
    ACTN4 and the pathways associated with cell motility and adhesion contribute to the process of lung cancer metastasis to the brain.
    BMC Cancer. 2015;15:277.
    PubMed     Text format     Abstract available


    January 2015
  42. TIAN Y, Xie Q, He J, Luo X, et al
    Radioactive (125)I seeds inhibit cell growth and epithelial-mesenchymal transition in human glioblastoma multiforme via a ROS-mediated signaling pathway.
    BMC Cancer. 2015;15:1.
    PubMed     Text format     Abstract available


  43. MICALE L, Fusco C, Fontana A, Barbano R, et al
    TRIM8 downregulation in glioma affects cell proliferation and it is associated with patients survival.
    BMC Cancer. 2015;15:470.
    PubMed     Text format     Abstract available


  44. GIMENEZ M, Marie SK, Oba-Shinjo S, Uno M, et al
    Quantitative proteomic analysis shows differentially expressed HSPB1 in glioblastoma as a discriminating short from long survival factor and NOVA1 as a differentiation factor between low-grade astrocytoma and oligodendroglioma.
    BMC Cancer. 2015;15:481.
    PubMed     Text format     Abstract available


  45. SCORSETTI M, Navarria P, Pessina F, Ascolese AM, et al
    Multimodality therapy approaches, local and systemic treatment, compared with chemotherapy alone in recurrent glioblastoma.
    BMC Cancer. 2015;15:486.
    PubMed     Text format     Abstract available


  46. TOWNER RA, Ihnat M, Saunders D, Bastian A, et al
    A new anti-glioma therapy, AG119: pre-clinical assessment in a mouse GL261 glioma model.
    BMC Cancer. 2015;15:522.
    PubMed     Text format     Abstract available


  47. HAUSWALD H, Stenke A, Debus J, Combs SE, et al
    Linear accelerator-based stereotactic radiosurgery in 140 brain metastases from malignant melanoma.
    BMC Cancer. 2015;15:537.
    PubMed     Text format     Abstract available


  48. ADEBERG S, Bostel T, Harrabi S, Bernhardt D, et al
    Impact of delays in initiating postoperative chemoradiation while determining the MGMT promoter-methylation statuses of patients with primary glioblastoma.
    BMC Cancer. 2015;15:558.
    PubMed     Text format     Abstract available


  49. OZAWA Y, Omae M, Fujii M, Matsui T, et al
    Management of brain metastasis with magnetic resonance imaging and stereotactic irradiation attenuated benefits of prophylactic cranial irradiation in patients with limited-stage small cell lung cancer.
    BMC Cancer. 2015;15:589.
    PubMed     Text format     Abstract available


  50. HAN S, Liu Y, Li Q, Li Z, et al
    Pre-treatment neutrophil-to-lymphocyte ratio is associated with neutrophil and T-cell infiltration and predicts clinical outcome in patients with glioblastoma.
    BMC Cancer. 2015;15:617.
    PubMed     Text format     Abstract available


  51. ADKINS CE, Nounou MI, Hye T, Mohammad AS, et al
    NKTR-102 Efficacy versus irinotecan in a mouse model of brain metastases of breast cancer.
    BMC Cancer. 2015;15:685.
    PubMed     Text format     Abstract available


  52. FABBRI E, Brognara E, Montagner G, Ghimenton C, et al
    Regulation of IL-8 gene expression in gliomas by microRNA miR-93.
    BMC Cancer. 2015;15:661.
    PubMed     Text format     Abstract available


  53. LAMBERTZ N, El Hindy N, Kreitschmann-Andermahr I, Stein KP, et al
    Downregulation of programmed cell death 10 is associated with tumor cell proliferation, hyperangiogenesis and peritumoral edema in human glioblastoma.
    BMC Cancer. 2015;15:759.
    PubMed     Text format     Abstract available


  54. MARTINEZ R, Stuhmer W, Martin S, Schell J, et al
    Analysis of the expression of Kv10.1 potassium channel in patients with brain metastases and glioblastoma multiforme: impact on survival.
    BMC Cancer. 2015;15:839.
    PubMed     Text format     Abstract available


  55. GU XD, Cai YT, Zhou YM, Li ZY, et al
    Prognostic factors and multidisciplinary treatment modalities for brain metastases from colorectal cancer: analysis of 93 patients.
    BMC Cancer. 2015;15:902.
    PubMed     Text format     Abstract available


  56. WEISS S, Darvishian F, Tadepalli J, Shapiro R, et al
    Somatic and germline analyses of a long term melanoma survivor with a recurrent brain metastasis.
    BMC Cancer. 2015;15:926.
    PubMed     Text format     Abstract available


  57. CHAN V, Pole JD, Mann RE, Colantonio A, et al
    A population based perspective on children and youth with brain tumours.
    BMC Cancer. 2015;15:1007.
    PubMed     Text format     Abstract available


  58. ZHANG C, Zhu Q, He H, Jiang L, et al
    RIZ1: a potential tumor suppressor in glioma.
    BMC Cancer. 2015;15:990.
    PubMed     Text format     Abstract available


  59. LEE SJ, Kang WY, Yoon Y, Jin JY, et al
    Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain.
    BMC Cancer. 2015;15:1011.
    PubMed     Text format     Abstract available


  60. CHENG CL, Li CC, Hou HA, Fang WQ, et al
    Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults.
    BMC Cancer. 2015;15:344.
    PubMed     Text format     Abstract available


  61. WU PF, Lin CH, Kuo CH, Chen WW, et al
    A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis.
    BMC Cancer. 2015;15:299.
    PubMed     Text format     Abstract available


  62. GAO H, Wang F, Lan X, Li C, et al
    Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomas.
    BMC Cancer. 2015;15:272.
    PubMed     Text format     Abstract available


  63. RESENDE FF, Bai X, Del Bel EA, Kirchhoff F, et al
    Evaluation of TgH(CX3CR1-EGFP) mice implanted with mCherry-GL261 cells as an in vivo model for morphometrical analysis of glioma-microglia interaction.
    BMC Cancer. 2016;16:72.
    PubMed     Text format     Abstract available


  64. JUNGK C, Chatziaslanidou D, Ahmadi R, Capper D, et al
    Chemotherapy with BCNU in recurrent glioma: Analysis of clinical outcome and side effects in chemotherapy-naive patients.
    BMC Cancer. 2016;16:81.
    PubMed     Text format     Abstract available


  65. YANG L, Fujimoto J
    Childhood cancer mortality in Japan, 1980-2013.
    BMC Cancer. 2015;15:446.
    PubMed     Text format     Abstract available


  66. TANAKA T, Hiramatsu K, Nosaka T, Saito Y, et al
    Pituitary metastasis of hepatocellular carcinoma presenting with panhypopituitarism: a case report.
    BMC Cancer. 2015;15:863.
    PubMed     Text format     Abstract available


    October 2014
  67. ZHANG W, Jiang W, Luan L, Wang L, et al
    Prophylactic cranial irradiation for patients with small-cell lung cancer: a systematic review of the literature with meta-analysis.
    BMC Cancer. 2014;14:793.
    PubMed     Text format     Abstract available


    September 2014
  68. VAN LAAR M, Stark DP, McKinney P, Parslow RC, et al
    Population mixing for leukaemia, lymphoma and CNS tumours in teenagers and young adults in England, 1996-2005.
    BMC Cancer. 2014;14:698.
    PubMed     Text format     Abstract available


    August 2014
  69. SHAPOVALOV Y, Zettel M, Spielman SC, Amico-Ruvio SA, et al
    Fluoxetine modulates breast cancer metastasis to the brain in a murine model.
    BMC Cancer. 2014;14:598.
    PubMed     Text format     Abstract available


    January 2014
  70. RADES D, Huttenlocher S, Hornung D, Blanck O, et al
    Radiosurgery alone versus radiosurgery plus whole-brain irradiation for very few cerebral metastases from lung cancer.
    BMC Cancer. 2014;14:931.
    PubMed     Text format     Abstract available


  71. LIU BL, Liu SJ, Baskys A, Cheng H, et al
    Platinum sensitivity and CD133 expression as risk and prognostic predictors of central nervous system metastases in patients with epithelial ovarian cancer.
    BMC Cancer. 2014;14:829.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: